Skip to menu Skip to content Skip to footer

Suppressor NKT cell trafficking to epithelial precancer (2010-2012)

Abstract

The clinical use of the body's immune system to attack existing cancers has met with limited success. Cancer often avoids the immune response by setting up a suppressive environment locally at the tumour. Our study addresses one component of this local environment which involves recruitment of a special subset of suppressive white blood cells - NKT cells. We will establish if drugs can block their recruitment and prevent progression of the cancer.

Experts

Associate Professor Graham Leggatt

Affiliate Associate Professor of School of Biomedical Sciences
School of Biomedical Sciences
Faculty of Health, Medicine and Behavioural Sciences
Associate Professor in Immunology
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
Graham Leggatt